Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims

The plan is expected to resolve 99.75% of all pending talc lawsuits against the company and its units in the U.S., it said in a statement.

Previous post ‘I don’t have a travel buddy’: More older adults are flying solo by choice
Next post AMD’s mixed earnings reveal a company with a lot to prove — and the goods to do it